Grupo Famsa, S.A.B. de C.V.:戦略・SWOT・企業財務分析

◆英語タイトル:Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015271
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:小売
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Grupo Famsa, S.A.B. de C.V. – Strategy, SWOT and Corporate Finance Report
Summary

Grupo Famsa, S.A.B. de C.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Grupo Famsa, S.A.B. de C.V. (Groupo Famsa) is a specialty retailer. The company operates retail stores and banking branches. Through its retail stores, it offers furniture, electronics, household appliances, mobile phones, computers, motorcycles and others under Kurazai and Montemex brands. Through its banking branches, the company provides banking services, such as savings products comprising FamsaAhorro1-2-3, Pager and CD, Checking, Payroll, Internet banking, ATM, and AhorroNinos; and credit services comprising personal loan, Famsa credit card, and PYME credit. It operates in Mexico and the US. Groupo Famsa is headquartered in Monterrey, Nuevo Leon, Mexico.

Scope

- Detailed information on Grupo Famsa, S.A.B. de C.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Grupo Famsa, S.A.B. de C.V. in the form of a SWOT analysis
- An in-depth view of the business model of Grupo Famsa, S.A.B. de C.V. including a breakdown and examination of key business segments
- Intelligence on Grupo Famsa, S.A.B. de C.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Grupo Famsa, S.A.B. de C.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Grupo Famsa, S.A.B. de C.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Grupo Famsa, S.A.B. de C.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Grupo Famsa, S.A.B. de C.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Grupo Famsa, S.A.B. de C.V.: Company Overview
Grupo Famsa, S.A.B. de C.V.: Overview and Key Facts
Grupo Famsa, S.A.B. de C.V.: Overview
Grupo Famsa, S.A.B. de C.V.: Key Facts
Grupo Famsa, S.A.B. de C.V.: Key Employees
Grupo Famsa, S.A.B. de C.V.: Key Employee Biographies
Grupo Famsa, S.A.B. de C.V.: Major Products and Services
Grupo Famsa, S.A.B. de C.V.: Company History
Grupo Famsa, S.A.B. de C.V.: Management Statement
Grupo Famsa, S.A.B. de C.V.: Locations and Subsidiaries
Grupo Famsa, S.A.B. de C.V.: Key Competitors
Grupo Famsa, S.A.B. de C.V.: Company Analysis
Grupo Famsa, S.A.B. de C.V.: Business Description
Grupo Famsa, S.A.B. de C.V.: SWOT Analysis
Grupo Famsa, S.A.B. de C.V.: SWOT Overview
Grupo Famsa, S.A.B. de C.V.: Strengths
Grupo Famsa, S.A.B. de C.V.: Weaknesses
Grupo Famsa, S.A.B. de C.V.: Opportunities
Grupo Famsa, S.A.B. de C.V.: Threats
Grupo Famsa, S.A.B. de C.V.: Corporate Financial Deals Activity
Grupo Famsa, S.A.B. de C.V.: Financial Deals Overview
Grupo Famsa, S.A.B. de C.V.: Top Deals 2013 – 2017YTD*
Grupo Famsa, S.A.B. de C.V.: Advisors
Grupo Famsa, S.A.B. de C.V.: Top Legal Advisors
Grupo Famsa, S.A.B. de C.V.: Capital Raising
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Grupo Famsa, S.A.B. de C.V.: Key Facts
Table 2: Grupo Famsa, S.A.B. de C.V.: Key Employees
Table 3: Grupo Famsa, S.A.B. de C.V.: Locations and Subsidiaries
Table 4: Grupo Famsa, S.A.B. de C.V.: Key Competitors
Table 5: Grupo Famsa, S.A.B. de C.V.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Grupo Famsa, S.A.B. de C.V.: Top Deals 2013 - 2017YTD*
Table 7: Grupo Famsa, S.A.B. de C.V.: Legal Advisor Ranking by Value (US$m)
Table 8: Grupo Famsa, S.A.B. de C.V.: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 9: Grupo Famsa, S.A.B. de C.V.: Capital Raising by Deal Type (2013 - YTD*2017)

★海外企業調査レポート[Grupo Famsa, S.A.B. de C.V.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Andeavor (ANDV):石油・ガス:M&Aディール及び事業提携情報
    Summary Andeavor, formerly known as Tesoro Corporation (Tesoro), is a midstream company. It is one of the leading refiners and marketers of petroleum products in North America. The company principally undertakes transportation of crude oil, and manufacturing, transportation and sale of transportatio …
  • Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRO …
  • Dana-Farber Cancer Institute Inc:企業のM&A・事業提携・投資動向
    Dana-Farber Cancer Institute Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dana-Farber Cancer Institute Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in vitro diagnos …
  • Apotex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and d …
  • Domain Therapeutics SA-製薬・医療分野:企業M&A・提携分析
    Summary Domain Therapeutics SA (Domain Therapeutics) is a biopharmaceutical company that discovers and develops innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer by using transmembrane and G Protein-Coupled Receptor (GPCR) platform. Its pipeline consists o …
  • Interpace Diagnostics Group Inc (IDXG)-医療機器分野:企業M&A・提携分析
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; a …
  • Phoenix Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Jordan Ahli Bank PSC:企業の戦略・SWOT・財務分析
    Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Trillium Therapeutics Inc (TRIL):製薬・医療:M&Aディール及び事業提携情報
    Summary Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, is a clinical stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company’s lead program, TTI-621, a SIRPaFc fusion protein is being developed for hematological malignancies. …
  • Highland Gold Mining Limited:企業の戦略・SWOT・財務情報
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Advantage Oil & Gas Ltd. (AAV)-石油・ガス分野:企業M&A・提携分析
    Summary Advantage Oil & Gas Ltd. (Advantage Oil) is an upstream company that exploits, develops, acquires, and produces natural gas and liquids in Alberta. Its exploitation and development program is focused at Glacier. The company’s acreage is spread throughout the Western Canadian Sedimentary Basi …
  • Cipla Ltd (CIPLA):企業の財務・戦略的SWOT分析
    Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務分析
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Uranium One Inc:企業の戦略的SWOT分析
    Uranium One Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Integra LifeSciences Holdings Corp (IART)-医療機器分野:企業M&A・提携分析
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integra’s orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company’s neurosu …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Kore Potash Plc (ELM):企業の財務・戦略的SWOT分析
    Summary Kore Potash Plc (Kore Potash), formerly Elemental Minerals Ltd, is a mining company that offers exploration and development of mineral resources. The company offers development of potash project in the Republic of Congo and operates an exploration project in Australia. It also owns and opera …
  • Guangdong Carpoly Chemical Group Co Ltd:企業の戦略的SWOT分析
    Guangdong Carpoly Chemical Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆